LNX2
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| ligand of numb-protein X 2 | MIM:609733 | Ensembl:ENSG00000139517 | HGNC:HGNC:20421 | PA134899015 | 13q12.2 |
GO terms in LNX2
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0030165 | PDZ domain binding |
| MF | IEA | GO:0046872 | metal ion binding |
| BP | IEA | GO:0051260 | protein homooligomerization |
Gene expression in normal tissue: LNX2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in LNX2
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD562 | Navitoclax | 1 |
| iGMDRD887 | Compound 23 citrate | 6 |
| iGMDRD871 | BRD6368 | 1 |
| iGMDRD286 | Nsc 632839 | 5 |
| iGMDRD100 | Zebularine | 5 |
| iGMDRD414 | MST-312 | 3 |
| iGMDRD23 | Gossypol | 2 |
| iGMDRD60 | Quinoclamine | 1 |
| iGMDRD300 | Tozasertib | 3 |
| iGMDRD52 | Rotenone | 3 |
| iGMDRD267 | Oligomycin A | 2 |
| iGMDRD705 | Nakiterpiosin | 6 |
| iGMDRD221 | Tamoxifen | 1 |
| iGMDRD219 | Bax channel blocker | 1 |
| iGMDRD499 | PDMP | 1 |
| iGMDRD375 | GW-405833 | 5 |
| iGMDRD634 | SCHEMBL2608041 | 2 |
| iGMDRD280 | CYTOCHALASIN B | 6 |
| iGMDRD889 | Compound 7d-cis | 2 |
| iGMDRD512 | nutlin 3 | 6 |
| iGMDRD554 | CHEMBL1434137 | 3 |
| iGMDRD484 | Pluripotin | 6 |
| iGMDRD79 | Gemcitabine | 2 |
| iGMDRD483 | SCH-529074 | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in LNX2
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.